Results 1 - 10 of 1425
Results 1 - 10 of 1425. Search took: 0.029 seconds
|Sort by: date | relevance|
[en] This report includes the issuances received during the specified period from the Commission (CLI), the Atomic Safety and Licensing Boards (LBP), the Administrative Law Judges (ALJ), the Directors' Decisions (DD), and the Decisions on Petitions for Rulemaking (DPRM). The summaries and headnotes preceding the opinions reported herein are not to be deemed a part of those opinions or have any independent legal significance
Background and PurposeData on safety and efficacy of periprocedural use of heparin are limited during treatment of acute ischemic stroke patients with anterior circulation tandem occlusion. This study aimed to investigate the impact of heparin use during endovascular therapy of anterior circulation tandem occlusions on the functional and safety outcomes.
MethodsA retrospective analysis of the multicenter observational TITAN registry was performed. Patients with anterior circulation tandem occlusion and treated with endovascular therapy (EVT) were included, with or without extracranial carotid intervention. We divided patients into two groups based on periprocedural heparin use (heparin vs. non-heparin). The dose of intravenous unfractionated heparin ranged from 1500 to 2500 I.U. Primary study endpoint was 90-day Modified Rankin Scale (mRS). Secondary study endpoint included angiographic and safety endpoints such as hemorrhagic complications. A propensity-score-matched analysis was performed.
ResultsAmong 369 patients, heparin was used in 68 patients (18.4%). In the propensity-score-matched cohort, favorable outcome (mRS 0–2) occurred in 51.3% in heparin group and 58.0% in non-heparin group (matched OR, 0.76; 95% CI, 0.32–1.78; P = 0.52). Similar result was found in propensity-score-adjusted cohort (adjusted OR, 0.72; 95%CI, 0.39–1.32; P = 0.28). Likewise, there was no difference in the rate of successful reperfusion (mTICI 2b-3) (propensity-score-adjusted OR, 1.03; 95%CI, 0.50–2.09; P = 0.93) neither in safety endpoints between the two groups.
ConclusionsPeriprocedural heparin use during EVT of anterior circulation tandem occlusions was not associated with better functional, angiographic or safety outcomes. These findings are applicable for low doses of heparin, and further studies are warranted.
[en] This is the final report on the series of operations which culminated with the delivery of the Plasma Separation Process prototype magnet system (PMS) to Building K1432 at Oak Ridge National Laboratory (ORNL). This procedure included real time monitoring of the cold mass support strut strain gauges and an in-cab rider to monitor the instrumentation and direct the driver. The primary technical consideration for these precautions was the possibility of low frequency resonant vibration of the cold mass when excited by symmetrical rough road conditions at specific speeds causing excess stress levels in the support struts and consequent strut failure. A secondary consideration was the possibility of high acceleration loads due to sudden stops, severe road conditions, of impacts. The procedure for moving and transportation to ORNL included requirements for real time continuous monitoring of the eight strut stain gauges and three external accelerometers. Because the strain gauges had not been used since the original magnet cooldown, it was planned to verify their integrity during magnet warmup. The measurements made from the strut strain gauges resulted in stress values that were physically impossible. It was concluded that further evaluation was necessary to verify the usefulness of these gauges and whether they might be faulty. This was accomplished during the removal of the magnet from the building. 6 figs., 1 tab
[en] In the past, the selection of representative accidents for refined analysis from the numerous scenarios identified in hazards analyses (HAs) has involved significant judgment and has been difficult to defend. As part of upgrading the Final Safety Analysis Report (FSAR) for the TA-55 plutonium facility at the Los Alamos National Laboratory, an accident selection process was developed that is mostly mechanical and reproducible in nature and fulfills the requirements of the Department of Energy (DOE) Standard 3009 and DOE Order 5480.23. Among the objectives specified by this guidance are the requirements that accident screening (1) consider accidents during normal and abnormal operating conditions, (2) consider both design basis and beyond design basis accidents, (3) characterize accidents by category (operational, natural phenomena, etc.) and by type (spill, explosion, fire, etc.), and (4) identify accidents that bound all foreseeable accident types. The accident selection process described here in the context of the TA-55 FSAR is applicable to all types of DOE facilities
[en] This report includes the issuances received during the specified period from the Commission, the Atomic Safety and Licensing Boards, the Administrative Law Judges, the Directors' Decisions, and the Decisions on Petitions for Rulemaking
[en] The Regulatory Agenda is a quarterly compilation of all rules on which the NRC has proposed, or is considering action as well as those on which it has recently completed action, and all petitions for rulemaking which have been received and are pending disposition by the Commission
[en] This compilation consists of bibliographic data and abstracts for the formal regulatory and technical reports issued by the U.S. Nuclear Regulatory Commission (NRC) Staff and its contractors. This compilation is published quarterly and cummulated annually. Reports consist of staff-originated reports, NRC-sponsored conference reports, NRC contractor-prepared reports, and international agreement reports
[en] A digest is given of a number of Commission, Atomic Safety and Licensing Appeal Board, and Atomic Safety and Licensing Board decisions issued during the period from July 1, 1972 to March 31, 1986, interpreting the NRC's Rules of Practice. Parts of earlier editions and supplements are replaced, and amendments to the Rules of Practice effective through March 31, 1986 are reflected. The material included deals with applications, prehearing matters, hearings, post-hearing matters, appeals, and decisions related to general matters. Decisions are indexed by facility, citation, CFR, statutes, case law, and other legal citations
[en] Fermilab has adopted the Source Evaluation Board (SEB) method for procuring certain major technical components of the Fermilab Main Injector. The SEB procedure is designed to ensure the efficient and effective expenditure of Government funds at the same time that it optimizes the opportunity for attainment of project objectives. A qualitative trade-off is allowed between price and technical factors. The process involves a large amount of work and is only justified for a very limited number of procurements. Fermilab has gained experience with the SEB process in awarding subcontracts for major subassemblies of the Fermilab Main Injector dipoles